|
BRIEF-Protagonist Therapeutics appoints Five Prime Therapeutics CEO to board of directors
Reuters June 8 Protagonist Therapeutics Inc: * Protagonist Therapeutics appoints Five Prime Therapeutics CEO, Lewis T. “Rusty” Williams, to its board of directors Source text for Eikon: Further company coverage: Our Standards: The Thomson Reuters Trust … |
June 08, 2017 at 06:16PM
from
No comments:
Post a Comment